# EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Annual P&L / Income Statement

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: 2025-01-01 to 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-25, accession number 0001099800-26-000009
- Page: https://plicit.ai/financials/ew/fy2025-annual-income-statement
- Chart image: https://plicit.ai/charts/ew-fy2025-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2025-01-01 through 2025-12-31. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 6,067,600,000 US dollars
- **Cost of sales**: 1,334,200,000 US dollars
- **Gross profit**: 4,733,400,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 3,469,200,000 US dollars
- **Operating income**: 1,264,200,000 US dollars
- **Other income (expense), net (calculated)**: 8,700,000 US dollars
- **Income from continuing operations before provision for income taxes**: 1,272,900,000 US dollars
- **Provision for income taxes (Note 19)**: 216,900,000 US dollars
- **Net income**: 1,069,400,000 US dollars
- **Transcatheter Aortic Valve Replacement**: 4,487,700,000 US dollars
- **Transcatheter Mitral and Tricuspid Therapies**: 550,600,000 US dollars
- **Surgical Structural Heart**: 1,029,300,000 US dollars
- **Selling, general, and administrative expenses**: 2,085,200,000 US dollars
- **Research and development expenses**: 1,079,200,000 US dollars
- **Intellectual property agreement and certain litigation expenses (Note 3)**: 325,400,000 US dollars
- **Change in fair value of contingent consideration liabilities (Note 13)**: negative 12,500,000 US dollars
- **Restructuring charges, separation costs, and other (Note 4)**: 19,100,000 US dollars
- **Intangible assets impairment charges**: 40,000,000 US dollars
- **Other operating income**: negative 67,200,000 US dollars
- **Income from discontinued operations, net of tax**: 13,400,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $1.07 B; to noncontrolling interests: −$4.10 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/ew/fy2025-annual-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/ew-fy2025-annual-revenue-by-business-segment-sankey.png

Income statement for 2025-01-01 through 2025-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 6,067,600,000 US dollars
- **Cost of sales**: 1,334,200,000 US dollars
- **Gross profit**: 4,733,400,000 US dollars
- **Operating costs, net of other operating income (calculated)**: 3,469,200,000 US dollars
- **Operating income**: 1,264,200,000 US dollars
- **Other income (expense), net (calculated)**: 8,700,000 US dollars
- **Income from continuing operations before provision for income taxes**: 1,272,900,000 US dollars
- **Provision for income taxes (Note 19)**: 216,900,000 US dollars
- **Net income**: 1,069,400,000 US dollars
- **United States**: 3,543,100,000 US dollars
- **Europe**: 1,517,500,000 US dollars
- **Japan**: 354,700,000 US dollars
- **Rest of World**: 652,300,000 US dollars
- **Selling, general, and administrative expenses**: 2,085,200,000 US dollars
- **Research and development expenses**: 1,079,200,000 US dollars
- **Intellectual property agreement and certain litigation expenses (Note 3)**: 325,400,000 US dollars
- **Change in fair value of contingent consideration liabilities (Note 13)**: negative 12,500,000 US dollars
- **Restructuring charges, separation costs, and other (Note 4)**: 19,100,000 US dollars
- **Intangible assets impairment charges**: 40,000,000 US dollars
- **Other operating income**: negative 67,200,000 US dollars
- **Income from discontinued operations, net of tax**: 13,400,000 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
- Of which attributable to EDWARDS LIFESCIENCES CORPORATION: $1.07 B; to noncontrolling interests: −$4.10 M.